Trial · NCT07913945
One Inch Punch High Impact Training Randomized Control Trial (1'' Punch HIT RCT)
NCT07913945, Not applicable, Not yet recruiting, The University of Hong Kong
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. One Inch Punch High Impact Training Randomized Control Trial (1'' Punch HIT RCT). Trials, record NCT07913945. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07913945
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- One Inch Punch High Impact Training Randomized Control Trial (1'' Punch HIT RCT)
- NCT number
- NCT07913945
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 102 participants, estimated
- Lead sponsor
- The University of Hong Kong
- Conditions
- Distal Radius Fracture
- Interventions
- Standard rehabilitation + one-inch punch training, Standard rehabilitation
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Region-specific patient-reported functional outcome score | At post-op 6 weeks, 12 weeks, 6 months, and 12 months | Physical function and symptoms measured by the Shortened Disabilities of the Arm, Shoulder and Hand Questionnaire (QuickDASH), an 11-item patient-reported measure with a total score ranging from 0 (no disability) to 100 (most severe disability). |
| Primary | Health-related Quality of Life Measured by SF-12 Chinese (HK) Version | At post-op 6 weeks, 12 weeks, 6 months, and 12 months | 12-item Short Form Health Survey (SF-12), a patient-reported outcome measure of HRQOL comprised of a mental component (MCS) and physical component (PCS), each with a final score ranging from 0 (worst outcome) to 100 (best outcome). |
| Secondary | Grip strength | At post-op 6 weeks, 12 weeks, 6 months, and 12 months | Grip strength will be measured using an electronic dynamometer |
| Secondary | Range of motion | At post-op 6 weeks, 12 weeks, 6 months, and 12 months | The patient's wrist range of motion, including pronation, supination, flexion, extension, and radial/ulnar deviation, will be measured. |
| Secondary | Radiographic outcomes | At post-op 6 weeks, 12 weeks, 6 months, and 12 months | Patients' X-rays will be assessed for fracture healing, implant migration, and fracture displacement. |
| Secondary | Numeric Pain Rating Scale (NPRS) | At post-op 6 weeks, 12 weeks, 6 months, and 12 months | A standard 11-point patient-reported measure used to measure pain intensity from 0 (no pain) to 10 (extreme pain). |
| Secondary | Peak striking force | At post-op 6 weeks, 12 weeks, 6 months, and 12 months | The peak striking force of the patient's punch will be measured using a force plate. |
| Secondary | Incidence of complications | At post-op 6 weeks, 12 weeks, 6 months, and 12 months | Incidence of wound breakdown, infection, CRPS, tendon irritation, implant failure including screw breakage, and re-operation |
| Secondary | Qualitative self-reported compliance | At post-op 6 weeks, 12 weeks, 6 months, and 12 months | Patients' self-reported score on their compliance with the rehabilitation sessions and home exercise based on a Likert Scale of 1 (Did not follow) to 5 (Fully comply) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers6
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07913945
GET https://conductscience.org/api/trials/v1/NCT07913945/registered